🇺🇸 FDA
Pipeline program

Placebo

RLM-MD-04

Phase 3 small_molecule terminated

Quick answer

Placebo for Gastroparesis is a Phase 3 program (small_molecule) at Allergan Pharmaceuticals International Limited with 3 ClinicalTrials.gov record(s).

Program details

Company
Allergan Pharmaceuticals International Limited
Indication
Gastroparesis
Phase
Phase 3
Modality
small_molecule
Status
terminated

Clinical trials